details

The first Clinical Cancer Genomics Conference (CCG2025) will take place in Amsterdam from 20 to 21 March 2025. This new annual conference will focus on the integration of modern genomic approaches into research and clinical practice. Under the motto ‘Whole genomes and transcriptomes: from clinic to research and back’, the conference will highlight the latest developments in genomic cancer medicine.

CCG2025 marks the 10th anniversary of the Hartwig Medical Foundation (Netherlands) and is being organised in collaboration with leading institutions:

• Hartwig Medical Foundation
• National Center for Tumor Diseases (NCT)
• 2025 French Genomic Medicine Initiative 
• Genomics England
• Genomic Medicine Sweden
• Danish National Genome Center

Stefan Fröhling, Managing Director of the National Center for Tumour Diseases (NCT) Heidelberg and Head of the Division of Translational Medical Oncology at the German Cancer Research Center (DKFZ), is one of the co-organisers of the conference. He will talk about the DKFZ/NCT/DKTK MASTER programme and whole-genome and whole-transcriptome sequencing for precision oncology in Germany. Another speaker is Eva Winkler, head of the Section for Translational Medical Ethics at the NCT Heidelberg and a member of the NCT Heidelberg's Executive Board. Her talk will focus on ethical aspects of the joint use of genomic data.

CCG2025 is not only intended to support the exchange of knowledge, but also to strengthen existing networks, promote international cooperation and initiate new projects.

Programme (download link)

Registration (until 15 January 2025) and further details: www.ccg2025.eu 

The first Clinical Cancer Genomics Conference (CCG2025) will take place in Amsterdam from 20 to 21 March 2025. This new annual conference will focus on the integration of modern genomic approaches into research and clinical practice. Under the motto ‘Whole genomes and transcriptomes: from clinic to research and back’, the conference will highlight the latest developments in genomic cancer medicine.

CCG2025 marks the 10th anniversary of the Hartwig Medical Foundation (Netherlands) and is being organised in collaboration with leading institutions:

• Hartwig Medical Foundation
• National Center for Tumor Diseases (NCT)
• 2025 French Genomic Medicine Initiative 
• Genomics England
• Genomic Medicine Sweden
• Danish National Genome Center

Stefan Fröhling, Managing Director of the National Center for Tumour Diseases (NCT) Heidelberg and Head of the Division of Translational Medical Oncology at the German Cancer Research Center (DKFZ), is one of the co-organisers of the conference. He will talk about the DKFZ/NCT/DKTK MASTER programme and whole-genome and whole-transcriptome sequencing for precision oncology in Germany. Another speaker is Eva Winkler, head of the Section for Translational Medical Ethics at the NCT Heidelberg and a member of the NCT Heidelberg's Executive Board. Her talk will focus on ethical aspects of the joint use of genomic data.

CCG2025 is not only intended to support the exchange of knowledge, but also to strengthen existing networks, promote international cooperation and initiate new projects.

Programme (download link)

Registration (until 15 January 2025) and further details: www.ccg2025.eu